Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Untreated Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00851136
What this trial is testing

PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 9
Testing effectiveness (Phase 2)WithdrawnNCT00003786
What this trial is testing

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago
Testing effectiveness (Phase 2)WithdrawnNCT00577109
What this trial is testing

Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00364013
What this trial is testing

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

Who this might be right for
Metastatic Colorectal Cancer
Amgen 1,183
Testing effectiveness (Phase 2)Study completedNCT03693170
What this trial is testing

Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer

Who this might be right for
BRAF V600E-mutant Metastatic Colorectal Cancer
Pierre Fabre Medicament 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07224022
What this trial is testing

Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer

Who this might be right for
Colon Cancer
John Strickler, M.D. 24
Testing effectiveness (Phase 2)Ended earlyNCT00320320
What this trial is testing

Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsMetastases
Gachon University Gil Medical Center 72
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT03050814
What this trial is testing

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

Who this might be right for
Colorectal TumorsColorectal NeoplasmsColorectal Carcinoma+2 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)UnknownNCT00021281
What this trial is testing

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00506571
What this trial is testing

Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorecal NeoplasmsSecondary
National Cancer Center, Korea 42
Testing effectiveness (Phase 2)Study completedNCT02305758
What this trial is testing

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Untreated Metastatic Colorectal Cancer
AbbVie 130
Testing effectiveness (Phase 2)Study completedNCT02743221
What this trial is testing

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 154
Testing effectiveness (Phase 2)Study completedNCT00940303
What this trial is testing

OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 97
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Ended earlyNCT00040391
What this trial is testing

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDiarrhea
Celgene Corporation
Large-scale testing (Phase 3)Study completedNCT00384176
What this trial is testing

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Who this might be right for
Colorectal Cancer
AstraZeneca 1,814
Testing effectiveness (Phase 2)Ended earlyNCT00449163
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Miami 25
Testing effectiveness (Phase 2)Study completedNCT03174405
What this trial is testing

Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial.

Who this might be right for
Metastatic Colorectal Cancer
AIO-Studien-gGmbH 43
Testing effectiveness (Phase 2)Study completedNCT00865709
What this trial is testing

Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

Who this might be right for
Metastatic Colorectal Cancer
Bayer 198
Next Page